0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Pharmaceutical Contract Manufacturing and Contract Market Research Report 2026
Published Date: 2026-02-27
|
Report Code: QYRE-Auto-0Y2665
Home | Market Reports
Global Pharmaceutical Contract Manufacturing and Contract Market Size Status and Forecast 2021 2027
BUY CHAPTERS

Global Pharmaceutical Contract Manufacturing and Contract Market Research Report 2026

Code: QYRE-Auto-0Y2665
Report
2026-02-27
Pages:134
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Pharmaceutical Contract Manufacturing and Contract Market Size

The global Pharmaceutical Contract Manufacturing and Contract market was valued at US$ 105060 million in 2025 and is anticipated to reach US$ 161220 million by 2032, at a CAGR of 6.4% from 2026 to 2032.

Pharmaceutical Contract Manufacturing and Contract Market

Pharmaceutical Contract Manufacturing and Contract Market

Contract pharmaceutical manufacturing refers to accept commissioned from pharmaceutical companies, provide the service about API production, agent production, packaging and son on which required for pharmaceutical manufacturing.
North America is the largest consumption place, with a consumption market share nearly 35% in 2018. Following North America, Europe is the second largest consumption place with the consumption market share of 23%.
This report delivers a comprehensive overview of the global Pharmaceutical Contract Manufacturing and Contract market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Pharmaceutical Contract Manufacturing and Contract. The Pharmaceutical Contract Manufacturing and Contract market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Pharmaceutical Contract Manufacturing and Contract market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Pharmaceutical Contract Manufacturing and Contract manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Pharmaceutical Contract Manufacturing and Contract Market Report

Report Metric Details
Report Name Pharmaceutical Contract Manufacturing and Contract Market
Accounted market size in 2025 US$ 105060 million
Forecasted market size in 2032 US$ 161220 million
CAGR 6.4%
Base Year 2025
Forecasted years 2026 - 2032
Segment by Type
  • Oral
  • Injectable
  • API
  • Other
Segment by Application
  • Small Medium Enterprise
  • Large Enterprise
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Catalent, Thermo Fisher Scientific, Lonza, Boehringer Ingelheim, Fareva, Recipharm, Aenova, AbbVie, Baxter, Nipro Corp, Sopharma, Famar, Vetter, Shandong Xinhua, Piramal, Mylan, Dr. Reddy’s, Zhejiang Hisun, Zhejiang Huahai, Jubilant
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
  • Chapter 3: Provides a detailed view of the competitive landscape for Pharmaceutical Contract Manufacturing and Contract companies, covering revenue share, development plans, and mergers and acquisitions.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
  • Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
  • Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
  • Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
  • Chapter 12: Key findings and conclusions of the report.

FAQ for this report

How fast is Pharmaceutical Contract Manufacturing and Contract Market growing?

Ans: The Pharmaceutical Contract Manufacturing and Contract Market witnessing a CAGR of 6.4% during the forecast period 2026-2032.

What is the Pharmaceutical Contract Manufacturing and Contract Market size in 2032?

Ans: The Pharmaceutical Contract Manufacturing and Contract Market size in 2032 will be US$ 161220 million.

What is the Pharmaceutical Contract Manufacturing and Contract Market share by region?

Ans: North America is the largest consumption place, with a consumption market share nearly 35% in 2018.

Who are the main players in the Pharmaceutical Contract Manufacturing and Contract Market report?

Ans: The main players in the Pharmaceutical Contract Manufacturing and Contract Market are Catalent, Thermo Fisher Scientific, Lonza, Boehringer Ingelheim, Fareva, Recipharm, Aenova, AbbVie, Baxter, Nipro Corp, Sopharma, Famar, Vetter, Shandong Xinhua, Piramal, Mylan, Dr. Reddy’s, Zhejiang Hisun, Zhejiang Huahai, Jubilant

What are the Application segmentation covered in the Pharmaceutical Contract Manufacturing and Contract Market report?

Ans: The Applications covered in the Pharmaceutical Contract Manufacturing and Contract Market report are Small Medium Enterprise, Large Enterprise

What are the Type segmentation covered in the Pharmaceutical Contract Manufacturing and Contract Market report?

Ans: The Types covered in the Pharmaceutical Contract Manufacturing and Contract Market report are Oral, Injectable, API, Other

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pharmaceutical Contract Manufacturing and Contract Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 Oral
1.2.3 Injectable
1.2.4 API
1.2.5 Other
1.3 Market by Application
1.3.1 Global Pharmaceutical Contract Manufacturing and Contract Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 Small Medium Enterprise
1.3.3 Large Enterprise
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Pharmaceutical Contract Manufacturing and Contract Market Perspective (2021–2032)
2.2 Global Pharmaceutical Contract Manufacturing and Contract Growth Trends by Region
2.2.1 Global Pharmaceutical Contract Manufacturing and Contract Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Pharmaceutical Contract Manufacturing and Contract Historic Market Size by Region (2021–2026)
2.2.3 Pharmaceutical Contract Manufacturing and Contract Forecasted Market Size by Region (2027–2032)
2.3 Pharmaceutical Contract Manufacturing and Contract Market Dynamics
2.3.1 Pharmaceutical Contract Manufacturing and Contract Industry Trends
2.3.2 Pharmaceutical Contract Manufacturing and Contract Market Drivers
2.3.3 Pharmaceutical Contract Manufacturing and Contract Market Challenges
2.3.4 Pharmaceutical Contract Manufacturing and Contract Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Pharmaceutical Contract Manufacturing and Contract Players by Revenue
3.1.1 Global Top Pharmaceutical Contract Manufacturing and Contract Players by Revenue (2021–2026)
3.1.2 Global Pharmaceutical Contract Manufacturing and Contract Revenue Market Share by Players (2021–2026)
3.2 Global Top Pharmaceutical Contract Manufacturing and Contract Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Pharmaceutical Contract Manufacturing and Contract Revenue
3.4 Global Pharmaceutical Contract Manufacturing and Contract Market Concentration Ratio
3.4.1 Global Pharmaceutical Contract Manufacturing and Contract Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pharmaceutical Contract Manufacturing and Contract Revenue in 2025
3.5 Global Key Players of Pharmaceutical Contract Manufacturing and Contract Head Offices and Areas Served
3.6 Global Key Players of Pharmaceutical Contract Manufacturing and Contract, Products and Applications
3.7 Global Key Players of Pharmaceutical Contract Manufacturing and Contract, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Pharmaceutical Contract Manufacturing and Contract Breakdown Data by Type
4.1 Global Pharmaceutical Contract Manufacturing and Contract Historic Market Size by Type (2021–2026)
4.2 Global Pharmaceutical Contract Manufacturing and Contract Forecasted Market Size by Type (2027–2032)
5 Pharmaceutical Contract Manufacturing and Contract Breakdown Data by Application
5.1 Global Pharmaceutical Contract Manufacturing and Contract Historic Market Size by Application (2021–2026)
5.2 Global Pharmaceutical Contract Manufacturing and Contract Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Pharmaceutical Contract Manufacturing and Contract Market Size (2021–2032)
6.2 North America Pharmaceutical Contract Manufacturing and Contract Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Pharmaceutical Contract Manufacturing and Contract Market Size by Country (2021–2026)
6.4 North America Pharmaceutical Contract Manufacturing and Contract Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Pharmaceutical Contract Manufacturing and Contract Market Size (2021–2032)
7.2 Europe Pharmaceutical Contract Manufacturing and Contract Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Pharmaceutical Contract Manufacturing and Contract Market Size by Country (2021–2026)
7.4 Europe Pharmaceutical Contract Manufacturing and Contract Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Pharmaceutical Contract Manufacturing and Contract Market Size (2021–2032)
8.2 Asia-Pacific Pharmaceutical Contract Manufacturing and Contract Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Pharmaceutical Contract Manufacturing and Contract Market Size by Region (2021–2026)
8.4 Asia-Pacific Pharmaceutical Contract Manufacturing and Contract Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Pharmaceutical Contract Manufacturing and Contract Market Size (2021–2032)
9.2 Latin America Pharmaceutical Contract Manufacturing and Contract Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Pharmaceutical Contract Manufacturing and Contract Market Size by Country (2021–2026)
9.4 Latin America Pharmaceutical Contract Manufacturing and Contract Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Pharmaceutical Contract Manufacturing and Contract Market Size (2021–2032)
10.2 Middle East & Africa Pharmaceutical Contract Manufacturing and Contract Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Pharmaceutical Contract Manufacturing and Contract Market Size by Country (2021–2026)
10.4 Middle East & Africa Pharmaceutical Contract Manufacturing and Contract Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Catalent
11.1.1 Catalent Company Details
11.1.2 Catalent Business Overview
11.1.3 Catalent Pharmaceutical Contract Manufacturing and Contract Introduction
11.1.4 Catalent Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2021–2026)
11.1.5 Catalent Recent Development
11.2 Thermo Fisher Scientific
11.2.1 Thermo Fisher Scientific Company Details
11.2.2 Thermo Fisher Scientific Business Overview
11.2.3 Thermo Fisher Scientific Pharmaceutical Contract Manufacturing and Contract Introduction
11.2.4 Thermo Fisher Scientific Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2021–2026)
11.2.5 Thermo Fisher Scientific Recent Development
11.3 Lonza
11.3.1 Lonza Company Details
11.3.2 Lonza Business Overview
11.3.3 Lonza Pharmaceutical Contract Manufacturing and Contract Introduction
11.3.4 Lonza Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2021–2026)
11.3.5 Lonza Recent Development
11.4 Boehringer Ingelheim
11.4.1 Boehringer Ingelheim Company Details
11.4.2 Boehringer Ingelheim Business Overview
11.4.3 Boehringer Ingelheim Pharmaceutical Contract Manufacturing and Contract Introduction
11.4.4 Boehringer Ingelheim Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2021–2026)
11.4.5 Boehringer Ingelheim Recent Development
11.5 Fareva
11.5.1 Fareva Company Details
11.5.2 Fareva Business Overview
11.5.3 Fareva Pharmaceutical Contract Manufacturing and Contract Introduction
11.5.4 Fareva Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2021–2026)
11.5.5 Fareva Recent Development
11.6 Recipharm
11.6.1 Recipharm Company Details
11.6.2 Recipharm Business Overview
11.6.3 Recipharm Pharmaceutical Contract Manufacturing and Contract Introduction
11.6.4 Recipharm Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2021–2026)
11.6.5 Recipharm Recent Development
11.7 Aenova
11.7.1 Aenova Company Details
11.7.2 Aenova Business Overview
11.7.3 Aenova Pharmaceutical Contract Manufacturing and Contract Introduction
11.7.4 Aenova Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2021–2026)
11.7.5 Aenova Recent Development
11.8 AbbVie
11.8.1 AbbVie Company Details
11.8.2 AbbVie Business Overview
11.8.3 AbbVie Pharmaceutical Contract Manufacturing and Contract Introduction
11.8.4 AbbVie Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2021–2026)
11.8.5 AbbVie Recent Development
11.9 Baxter
11.9.1 Baxter Company Details
11.9.2 Baxter Business Overview
11.9.3 Baxter Pharmaceutical Contract Manufacturing and Contract Introduction
11.9.4 Baxter Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2021–2026)
11.9.5 Baxter Recent Development
11.10 Nipro Corp
11.10.1 Nipro Corp Company Details
11.10.2 Nipro Corp Business Overview
11.10.3 Nipro Corp Pharmaceutical Contract Manufacturing and Contract Introduction
11.10.4 Nipro Corp Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2021–2026)
11.10.5 Nipro Corp Recent Development
11.11 Sopharma
11.11.1 Sopharma Company Details
11.11.2 Sopharma Business Overview
11.11.3 Sopharma Pharmaceutical Contract Manufacturing and Contract Introduction
11.11.4 Sopharma Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2021–2026)
11.11.5 Sopharma Recent Development
11.12 Famar
11.12.1 Famar Company Details
11.12.2 Famar Business Overview
11.12.3 Famar Pharmaceutical Contract Manufacturing and Contract Introduction
11.12.4 Famar Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2021–2026)
11.12.5 Famar Recent Development
11.13 Vetter
11.13.1 Vetter Company Details
11.13.2 Vetter Business Overview
11.13.3 Vetter Pharmaceutical Contract Manufacturing and Contract Introduction
11.13.4 Vetter Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2021–2026)
11.13.5 Vetter Recent Development
11.14 Shandong Xinhua
11.14.1 Shandong Xinhua Company Details
11.14.2 Shandong Xinhua Business Overview
11.14.3 Shandong Xinhua Pharmaceutical Contract Manufacturing and Contract Introduction
11.14.4 Shandong Xinhua Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2021–2026)
11.14.5 Shandong Xinhua Recent Development
11.15 Piramal
11.15.1 Piramal Company Details
11.15.2 Piramal Business Overview
11.15.3 Piramal Pharmaceutical Contract Manufacturing and Contract Introduction
11.15.4 Piramal Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2021–2026)
11.15.5 Piramal Recent Development
11.16 Mylan
11.16.1 Mylan Company Details
11.16.2 Mylan Business Overview
11.16.3 Mylan Pharmaceutical Contract Manufacturing and Contract Introduction
11.16.4 Mylan Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2021–2026)
11.16.5 Mylan Recent Development
11.17 Dr. Reddy’s
11.17.1 Dr. Reddy’s Company Details
11.17.2 Dr. Reddy’s Business Overview
11.17.3 Dr. Reddy’s Pharmaceutical Contract Manufacturing and Contract Introduction
11.17.4 Dr. Reddy’s Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2021–2026)
11.17.5 Dr. Reddy’s Recent Development
11.18 Zhejiang Hisun
11.18.1 Zhejiang Hisun Company Details
11.18.2 Zhejiang Hisun Business Overview
11.18.3 Zhejiang Hisun Pharmaceutical Contract Manufacturing and Contract Introduction
11.18.4 Zhejiang Hisun Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2021–2026)
11.18.5 Zhejiang Hisun Recent Development
11.19 Zhejiang Huahai
11.19.1 Zhejiang Huahai Company Details
11.19.2 Zhejiang Huahai Business Overview
11.19.3 Zhejiang Huahai Pharmaceutical Contract Manufacturing and Contract Introduction
11.19.4 Zhejiang Huahai Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2021–2026)
11.19.5 Zhejiang Huahai Recent Development
11.20 Jubilant
11.20.1 Jubilant Company Details
11.20.2 Jubilant Business Overview
11.20.3 Jubilant Pharmaceutical Contract Manufacturing and Contract Introduction
11.20.4 Jubilant Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2021–2026)
11.20.5 Jubilant Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global Pharmaceutical Contract Manufacturing and Contract Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
 Table 2. Key Players of Oral
 Table 3. Key Players of Injectable
 Table 4. Key Players of API
 Table 5. Key Players of Other
 Table 6. Global Pharmaceutical Contract Manufacturing and Contract Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
 Table 7. Global Pharmaceutical Contract Manufacturing and Contract Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 8. Global Pharmaceutical Contract Manufacturing and Contract Market Size by Region (US$ Million), 2021–2026
 Table 9. Global Pharmaceutical Contract Manufacturing and Contract Market Share by Region (2021–2026)
 Table 10. Global Pharmaceutical Contract Manufacturing and Contract Forecasted Market Size by Region (US$ Million), 2027–2032
 Table 11. Global Pharmaceutical Contract Manufacturing and Contract Market Share by Region (2027–2032)
 Table 12. Pharmaceutical Contract Manufacturing and Contract Market Trends
 Table 13. Pharmaceutical Contract Manufacturing and Contract Market Drivers
 Table 14. Pharmaceutical Contract Manufacturing and Contract Market Challenges
 Table 15. Pharmaceutical Contract Manufacturing and Contract Market Restraints
 Table 16. Global Pharmaceutical Contract Manufacturing and Contract Revenue by Players (US$ Million), 2021–2026
 Table 17. Global Pharmaceutical Contract Manufacturing and Contract Market Share by Players (2021–2026)
 Table 18. Global Top Pharmaceutical Contract Manufacturing and Contract Players by Tier (Tier 1, Tier 2, and Tier 3), based on Pharmaceutical Contract Manufacturing and Contract Revenue, 2025
 Table 19. Ranking of Global Top Pharmaceutical Contract Manufacturing and Contract Companies by Revenue (US$ Million) in 2025
 Table 20. Global 5 Largest Players Market Share by Pharmaceutical Contract Manufacturing and Contract Revenue (CR5 and HHI), 2021–2026
 Table 21. Global Key Players of Pharmaceutical Contract Manufacturing and Contract, Headquarters and Area Served
 Table 22. Global Key Players of Pharmaceutical Contract Manufacturing and Contract, Products and Applications
 Table 23. Global Key Players of Pharmaceutical Contract Manufacturing and Contract, Date of General Availability (GA)
 Table 24. Mergers and Acquisitions, Expansion Plans
 Table 25. Global Pharmaceutical Contract Manufacturing and Contract Market Size by Type (US$ Million), 2021–2026
 Table 26. Global Pharmaceutical Contract Manufacturing and Contract Revenue Market Share by Type (2021–2026)
 Table 27. Global Pharmaceutical Contract Manufacturing and Contract Forecasted Market Size by Type (US$ Million), 2027–2032
 Table 28. Global Pharmaceutical Contract Manufacturing and Contract Revenue Market Share by Type (2027–2032)
 Table 29. Global Pharmaceutical Contract Manufacturing and Contract Market Size by Application (US$ Million), 2021–2026
 Table 30. Global Pharmaceutical Contract Manufacturing and Contract Revenue Market Share by Application (2021–2026)
 Table 31. Global Pharmaceutical Contract Manufacturing and Contract Forecasted Market Size by Application (US$ Million), 2027–2032
 Table 32. Global Pharmaceutical Contract Manufacturing and Contract Revenue Market Share by Application (2027–2032)
 Table 33. North America Pharmaceutical Contract Manufacturing and Contract Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 34. North America Pharmaceutical Contract Manufacturing and Contract Market Size by Country (US$ Million), 2021–2026
 Table 35. North America Pharmaceutical Contract Manufacturing and Contract Market Size by Country (US$ Million), 2027–2032
 Table 36. Europe Pharmaceutical Contract Manufacturing and Contract Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 37. Europe Pharmaceutical Contract Manufacturing and Contract Market Size by Country (US$ Million), 2021–2026
 Table 38. Europe Pharmaceutical Contract Manufacturing and Contract Market Size by Country (US$ Million), 2027–2032
 Table 39. Asia-Pacific Pharmaceutical Contract Manufacturing and Contract Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 40. Asia-Pacific Pharmaceutical Contract Manufacturing and Contract Market Size by Region (US$ Million), 2021–2026
 Table 41. Asia-Pacific Pharmaceutical Contract Manufacturing and Contract Market Size by Region (US$ Million), 2027–2032
 Table 42. Latin America Pharmaceutical Contract Manufacturing and Contract Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 43. Latin America Pharmaceutical Contract Manufacturing and Contract Market Size by Country (US$ Million), 2021–2026
 Table 44. Latin America Pharmaceutical Contract Manufacturing and Contract Market Size by Country (US$ Million), 2027–2032
 Table 45. Middle East & Africa Pharmaceutical Contract Manufacturing and Contract Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 46. Middle East & Africa Pharmaceutical Contract Manufacturing and Contract Market Size by Country (US$ Million), 2021–2026
 Table 47. Middle East & Africa Pharmaceutical Contract Manufacturing and Contract Market Size by Country (US$ Million), 2027–2032
 Table 48. Catalent Company Details
 Table 49. Catalent Business Overview
 Table 50. Catalent Pharmaceutical Contract Manufacturing and Contract Product
 Table 51. Catalent Revenue in Pharmaceutical Contract Manufacturing and Contract Business (US$ Million), 2021–2026
 Table 52. Catalent Recent Development
 Table 53. Thermo Fisher Scientific Company Details
 Table 54. Thermo Fisher Scientific Business Overview
 Table 55. Thermo Fisher Scientific Pharmaceutical Contract Manufacturing and Contract Product
 Table 56. Thermo Fisher Scientific Revenue in Pharmaceutical Contract Manufacturing and Contract Business (US$ Million), 2021–2026
 Table 57. Thermo Fisher Scientific Recent Development
 Table 58. Lonza Company Details
 Table 59. Lonza Business Overview
 Table 60. Lonza Pharmaceutical Contract Manufacturing and Contract Product
 Table 61. Lonza Revenue in Pharmaceutical Contract Manufacturing and Contract Business (US$ Million), 2021–2026
 Table 62. Lonza Recent Development
 Table 63. Boehringer Ingelheim Company Details
 Table 64. Boehringer Ingelheim Business Overview
 Table 65. Boehringer Ingelheim Pharmaceutical Contract Manufacturing and Contract Product
 Table 66. Boehringer Ingelheim Revenue in Pharmaceutical Contract Manufacturing and Contract Business (US$ Million), 2021–2026
 Table 67. Boehringer Ingelheim Recent Development
 Table 68. Fareva Company Details
 Table 69. Fareva Business Overview
 Table 70. Fareva Pharmaceutical Contract Manufacturing and Contract Product
 Table 71. Fareva Revenue in Pharmaceutical Contract Manufacturing and Contract Business (US$ Million), 2021–2026
 Table 72. Fareva Recent Development
 Table 73. Recipharm Company Details
 Table 74. Recipharm Business Overview
 Table 75. Recipharm Pharmaceutical Contract Manufacturing and Contract Product
 Table 76. Recipharm Revenue in Pharmaceutical Contract Manufacturing and Contract Business (US$ Million), 2021–2026
 Table 77. Recipharm Recent Development
 Table 78. Aenova Company Details
 Table 79. Aenova Business Overview
 Table 80. Aenova Pharmaceutical Contract Manufacturing and Contract Product
 Table 81. Aenova Revenue in Pharmaceutical Contract Manufacturing and Contract Business (US$ Million), 2021–2026
 Table 82. Aenova Recent Development
 Table 83. AbbVie Company Details
 Table 84. AbbVie Business Overview
 Table 85. AbbVie Pharmaceutical Contract Manufacturing and Contract Product
 Table 86. AbbVie Revenue in Pharmaceutical Contract Manufacturing and Contract Business (US$ Million), 2021–2026
 Table 87. AbbVie Recent Development
 Table 88. Baxter Company Details
 Table 89. Baxter Business Overview
 Table 90. Baxter Pharmaceutical Contract Manufacturing and Contract Product
 Table 91. Baxter Revenue in Pharmaceutical Contract Manufacturing and Contract Business (US$ Million), 2021–2026
 Table 92. Baxter Recent Development
 Table 93. Nipro Corp Company Details
 Table 94. Nipro Corp Business Overview
 Table 95. Nipro Corp Pharmaceutical Contract Manufacturing and Contract Product
 Table 96. Nipro Corp Revenue in Pharmaceutical Contract Manufacturing and Contract Business (US$ Million), 2021–2026
 Table 97. Nipro Corp Recent Development
 Table 98. Sopharma Company Details
 Table 99. Sopharma Business Overview
 Table 100. Sopharma Pharmaceutical Contract Manufacturing and Contract Product
 Table 101. Sopharma Revenue in Pharmaceutical Contract Manufacturing and Contract Business (US$ Million), 2021–2026
 Table 102. Sopharma Recent Development
 Table 103. Famar Company Details
 Table 104. Famar Business Overview
 Table 105. Famar Pharmaceutical Contract Manufacturing and Contract Product
 Table 106. Famar Revenue in Pharmaceutical Contract Manufacturing and Contract Business (US$ Million), 2021–2026
 Table 107. Famar Recent Development
 Table 108. Vetter Company Details
 Table 109. Vetter Business Overview
 Table 110. Vetter Pharmaceutical Contract Manufacturing and Contract Product
 Table 111. Vetter Revenue in Pharmaceutical Contract Manufacturing and Contract Business (US$ Million), 2021–2026
 Table 112. Vetter Recent Development
 Table 113. Shandong Xinhua Company Details
 Table 114. Shandong Xinhua Business Overview
 Table 115. Shandong Xinhua Pharmaceutical Contract Manufacturing and Contract Product
 Table 116. Shandong Xinhua Revenue in Pharmaceutical Contract Manufacturing and Contract Business (US$ Million), 2021–2026
 Table 117. Shandong Xinhua Recent Development
 Table 118. Piramal Company Details
 Table 119. Piramal Business Overview
 Table 120. Piramal Pharmaceutical Contract Manufacturing and Contract Product
 Table 121. Piramal Revenue in Pharmaceutical Contract Manufacturing and Contract Business (US$ Million), 2021–2026
 Table 122. Piramal Recent Development
 Table 123. Mylan Company Details
 Table 124. Mylan Business Overview
 Table 125. Mylan Pharmaceutical Contract Manufacturing and Contract Product
 Table 126. Mylan Revenue in Pharmaceutical Contract Manufacturing and Contract Business (US$ Million), 2021–2026
 Table 127. Mylan Recent Development
 Table 128. Dr. Reddy’s Company Details
 Table 129. Dr. Reddy’s Business Overview
 Table 130. Dr. Reddy’s Pharmaceutical Contract Manufacturing and Contract Product
 Table 131. Dr. Reddy’s Revenue in Pharmaceutical Contract Manufacturing and Contract Business (US$ Million), 2021–2026
 Table 132. Dr. Reddy’s Recent Development
 Table 133. Zhejiang Hisun Company Details
 Table 134. Zhejiang Hisun Business Overview
 Table 135. Zhejiang Hisun Pharmaceutical Contract Manufacturing and Contract Product
 Table 136. Zhejiang Hisun Revenue in Pharmaceutical Contract Manufacturing and Contract Business (US$ Million), 2021–2026
 Table 137. Zhejiang Hisun Recent Development
 Table 138. Zhejiang Huahai Company Details
 Table 139. Zhejiang Huahai Business Overview
 Table 140. Zhejiang Huahai Pharmaceutical Contract Manufacturing and Contract Product
 Table 141. Zhejiang Huahai Revenue in Pharmaceutical Contract Manufacturing and Contract Business (US$ Million), 2021–2026
 Table 142. Zhejiang Huahai Recent Development
 Table 143. Jubilant Company Details
 Table 144. Jubilant Business Overview
 Table 145. Jubilant Pharmaceutical Contract Manufacturing and Contract Product
 Table 146. Jubilant Revenue in Pharmaceutical Contract Manufacturing and Contract Business (US$ Million), 2021–2026
 Table 147. Jubilant Recent Development
 Table 148. Research Programs/Design for This Report
 Table 149. Key Data Information from Secondary Sources
 Table 150. Key Data Information from Primary Sources
 Table 151. Authors List of This Report


List of Figures
 Figure 1. Pharmaceutical Contract Manufacturing and Contract Picture
 Figure 2. Global Pharmaceutical Contract Manufacturing and Contract Market Size Comparison by Type (US$ Million), 2021–2032
 Figure 3. Global Pharmaceutical Contract Manufacturing and Contract Market Share by Type: 2025 vs 2032
 Figure 4. Oral Features
 Figure 5. Injectable Features
 Figure 6. API Features
 Figure 7. Other Features
 Figure 8. Global Pharmaceutical Contract Manufacturing and Contract Market Size by Application (US$ Million), 2021–2032
 Figure 9. Global Pharmaceutical Contract Manufacturing and Contract Market Share by Application: 2025 vs 2032
 Figure 10. Small Medium Enterprise Case Studies
 Figure 11. Large Enterprise Case Studies
 Figure 12. Pharmaceutical Contract Manufacturing and Contract Report Years Considered
 Figure 13. Global Pharmaceutical Contract Manufacturing and Contract Market Size (US$ Million), Year-over-Year: 2021–2032
 Figure 14. Global Pharmaceutical Contract Manufacturing and Contract Market Size, (US$ Million), 2021 vs 2025 vs 2032
 Figure 15. Global Pharmaceutical Contract Manufacturing and Contract Market Share by Region: 2025 vs 2032
 Figure 16. Global Pharmaceutical Contract Manufacturing and Contract Market Share by Players in 2025
 Figure 17. Global Pharmaceutical Contract Manufacturing and Contract Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
 Figure 18. The Top 10 and 5 Players Market Share by Pharmaceutical Contract Manufacturing and Contract Revenue in 2025
 Figure 19. North America Pharmaceutical Contract Manufacturing and Contract Market Size YoY Growth (US$ Million), 2021–2032
 Figure 20. North America Pharmaceutical Contract Manufacturing and Contract Market Share by Country (2021–2032)
 Figure 21. United States Pharmaceutical Contract Manufacturing and Contract Market Size YoY Growth (US$ Million), 2021–2032
 Figure 22. Canada Pharmaceutical Contract Manufacturing and Contract Market Size YoY Growth (US$ Million), 2021–2032
 Figure 23. Europe Pharmaceutical Contract Manufacturing and Contract Market Size YoY Growth (US$ Million), 2021–2032
 Figure 24. Europe Pharmaceutical Contract Manufacturing and Contract Market Share by Country (2021–2032)
 Figure 25. Germany Pharmaceutical Contract Manufacturing and Contract Market Size YoY Growth (US$ Million), 2021–2032
 Figure 26. France Pharmaceutical Contract Manufacturing and Contract Market Size YoY Growth (US$ Million), 2021–2032
 Figure 27. U.K. Pharmaceutical Contract Manufacturing and Contract Market Size YoY Growth (US$ Million), 2021–2032
 Figure 28. Italy Pharmaceutical Contract Manufacturing and Contract Market Size YoY Growth (US$ Million), 2021–2032
 Figure 29. Russia Pharmaceutical Contract Manufacturing and Contract Market Size YoY Growth (US$ Million), 2021–2032
 Figure 30. Ireland Pharmaceutical Contract Manufacturing and Contract Market Size YoY Growth (US$ Million), 2021–2032
 Figure 31. Asia-Pacific Pharmaceutical Contract Manufacturing and Contract Market Size YoY Growth (US$ Million), 2021–2032
 Figure 32. Asia-Pacific Pharmaceutical Contract Manufacturing and Contract Market Share by Region (2021–2032)
 Figure 33. China Pharmaceutical Contract Manufacturing and Contract Market Size YoY Growth (US$ Million), 2021–2032
 Figure 34. Japan Pharmaceutical Contract Manufacturing and Contract Market Size YoY Growth (US$ Million), 2021–2032
 Figure 35. South Korea Pharmaceutical Contract Manufacturing and Contract Market Size YoY Growth (US$ Million), 2021–2032
 Figure 36. Southeast Asia Pharmaceutical Contract Manufacturing and Contract Market Size YoY Growth (US$ Million), 2021–2032
 Figure 37. India Pharmaceutical Contract Manufacturing and Contract Market Size YoY Growth (US$ Million), 2021–2032
 Figure 38. Australia & New Zealand Pharmaceutical Contract Manufacturing and Contract Market Size YoY Growth (US$ Million), 2021–2032
 Figure 39. Latin America Pharmaceutical Contract Manufacturing and Contract Market Size YoY Growth (US$ Million), 2021–2032
 Figure 40. Latin America Pharmaceutical Contract Manufacturing and Contract Market Share by Country (2021–2032)
 Figure 41. Mexico Pharmaceutical Contract Manufacturing and Contract Market Size YoY Growth (US$ Million), 2021–2032
 Figure 42. Brazil Pharmaceutical Contract Manufacturing and Contract Market Size YoY Growth (US$ Million), 2021–2032
 Figure 43. Middle East & Africa Pharmaceutical Contract Manufacturing and Contract Market Size YoY Growth (US$ Million), 2021–2032
 Figure 44. Middle East & Africa Pharmaceutical Contract Manufacturing and Contract Market Share by Country (2021–2032)
 Figure 45. Israel Pharmaceutical Contract Manufacturing and Contract Market Size YoY Growth (US$ Million), 2021–2032
 Figure 46. Saudi Arabia Pharmaceutical Contract Manufacturing and Contract Market Size YoY Growth (US$ Million), 2021–2032
 Figure 47. UAE Pharmaceutical Contract Manufacturing and Contract Market Size YoY Growth (US$ Million), 2021–2032
 Figure 48. Catalent Revenue Growth Rate in Pharmaceutical Contract Manufacturing and Contract Business (2021–2026)
 Figure 49. Thermo Fisher Scientific Revenue Growth Rate in Pharmaceutical Contract Manufacturing and Contract Business (2021–2026)
 Figure 50. Lonza Revenue Growth Rate in Pharmaceutical Contract Manufacturing and Contract Business (2021–2026)
 Figure 51. Boehringer Ingelheim Revenue Growth Rate in Pharmaceutical Contract Manufacturing and Contract Business (2021–2026)
 Figure 52. Fareva Revenue Growth Rate in Pharmaceutical Contract Manufacturing and Contract Business (2021–2026)
 Figure 53. Recipharm Revenue Growth Rate in Pharmaceutical Contract Manufacturing and Contract Business (2021–2026)
 Figure 54. Aenova Revenue Growth Rate in Pharmaceutical Contract Manufacturing and Contract Business (2021–2026)
 Figure 55. AbbVie Revenue Growth Rate in Pharmaceutical Contract Manufacturing and Contract Business (2021–2026)
 Figure 56. Baxter Revenue Growth Rate in Pharmaceutical Contract Manufacturing and Contract Business (2021–2026)
 Figure 57. Nipro Corp Revenue Growth Rate in Pharmaceutical Contract Manufacturing and Contract Business (2021–2026)
 Figure 58. Sopharma Revenue Growth Rate in Pharmaceutical Contract Manufacturing and Contract Business (2021–2026)
 Figure 59. Famar Revenue Growth Rate in Pharmaceutical Contract Manufacturing and Contract Business (2021–2026)
 Figure 60. Vetter Revenue Growth Rate in Pharmaceutical Contract Manufacturing and Contract Business (2021–2026)
 Figure 61. Shandong Xinhua Revenue Growth Rate in Pharmaceutical Contract Manufacturing and Contract Business (2021–2026)
 Figure 62. Piramal Revenue Growth Rate in Pharmaceutical Contract Manufacturing and Contract Business (2021–2026)
 Figure 63. Mylan Revenue Growth Rate in Pharmaceutical Contract Manufacturing and Contract Business (2021–2026)
 Figure 64. Dr. Reddy’s Revenue Growth Rate in Pharmaceutical Contract Manufacturing and Contract Business (2021–2026)
 Figure 65. Zhejiang Hisun Revenue Growth Rate in Pharmaceutical Contract Manufacturing and Contract Business (2021–2026)
 Figure 66. Zhejiang Huahai Revenue Growth Rate in Pharmaceutical Contract Manufacturing and Contract Business (2021–2026)
 Figure 67. Jubilant Revenue Growth Rate in Pharmaceutical Contract Manufacturing and Contract Business (2021–2026)
 Figure 68. Bottom-up and Top-down Approaches for This Report
 Figure 69. Data Triangulation
 Figure 70. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Samsung SD

SIMILAR REPORTS